Resistin impairs glucose permeability in EA.hy926 cells by down-regulating GLUT1 expression

Area of Science:

• Endocrinology
• Metabolic Research
• Molecular Biology

Background:

• Type 2 diabetes mellitus (T2DM) is a growing global health concern.
• Resistin, a protein linked to metabolic dysfunction and obesity, is elevated during hyperglycemia.
• The role of resistin in glucose transport across the blood-tissue barrier remains unclear.

Purpose of the Study:

• To investigate if resistin mediates glucose transfer across the blood-tissue barrier.
• To elucidate the molecular mechanisms by which resistin affects glucose permeability.
• To explore the potential of targeting resistin for T2DM treatment.

Main Methods:

• Utilized a Transwell system with EA.hy926 human endothelial cells.
• Assessed glucose permeability in cells treated with or without human resistin.
• Analyzed GLUT1 expression, tight junction integrity, and peroxisome proliferator-activated receptor gamma (PPARγ) levels.

Main Results:

• Resistin significantly impaired glucose permeability in EA.hy926 cells.
• This impairment was attributed to resistin-induced down-regulation of GLUT1 expression, not tight junction alterations.
• Overexpression of GLUT1 reversed resistin's inhibitory effect on glucose permeability.
• Resistin was found to inhibit PPARγ expression, subsequently impeding GLUT1 transcription.

Conclusions:

• Resistin hinders glucose transfer across the blood-tissue barrier by down-regulating GLUT1 expression via PPARγ inhibition.
• This mechanism contributes to glucose retention in serum, potentially causing hyperglycemia.
• Resistin's role in glucose metabolism offers a novel explanation for hyperglycemia and a potential therapeutic target for T2DM.